Biotech Géant Context Therapeutics Attire des Talents avec des Récompenses en Actions Alléchantes
Context Therapeutics Inc., a Philadelphia-based biopharmaceutical company, offers attractively priced stock options to new hires, emphasising growth and innovation. The company focuses on T cell engaging bispecific antibodies, targeting solid tumours with groundbreaking therapeutics like Claudin 6 x CD3, Mesothelin x CD3,
